RESOURCES FOR HEALTHCARE PROFESSIONALS
Below you will find a range of resources to help you successfully integrate APRETUDE into your clinic, and equip you with the knowledge to feel confident discussing APRETUDE for pre-exposure prophylaxis (PrEP) with people in your care.
To view or download resources, please click the links below.
Administration Video
Correct preparation and administration is important, we are here to help you. Watch this video to learn more.
To support Healthcare Professionals (HCPs) in the implementation of APRETUDE into their clinical setting.
To support conversations with people who could benefit from APRETUDE, and ensure they have the relevant information to mitigate any possible concerns.
A simple appointment reminder tool designed to help individuals adhere to their long-acting PrEP injection appointments.
Available on request from your ViiV representative.
Information on who APRETUDE is for, how to initiate and dose correctly, storage and handling information, and information to support the use of APRETUDE in your practice.
References:
- APRETUDE (cabotegravir) 600 mg suspension for injection Summary of Product Characteristics (SmPC)
- https://www.medicines.org.uk/emc/search?q=apretude. Accessed April 2026.
PM-GB-CBT-WCNT-240007 April 2026
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK via the GSK Reporting Tool or on 0800 221441.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
